ABBREVIATIONS: ALPHA screen, amplifi ed luminescent proximity homogeneous assay; CMLD-BU, Center for Chemical Methodology and Library Development at Boston University; Core106, N-terminal 106-residue portion of core protein; CRC, control response curve; EC 50 , median effective concentration (required to induce a 50% effect); Eu, europium cryptate; FC, fl ag-core106; GC, GST-core106; GSH, glutathione; GST, glutathione-S-transferase; HBV, hepatitis B virus; HCV, hepatitis C virus; HPE, hundred percent effect; HRP, horseradish peroxidase; HTS, high-throughput screening; IC 50 , median inhibition concentration (concentration that reduces the effect by 50%); LOPAC, Library of Pharmacologically Active Compounds; SD, standard deviation; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TMB, 3,3′,5,5′-Tetramethylbenzidine; TR-FRET, time-resolved fl uorescence-resonance energy transfer; XL-665, allophycocyanin; ZPE, zero percent effect.
ABSTRACT
Binding of hepatitis C virus (HCV) RNA to core, the capsid protein, results in the formation of the nucleocapsid, the fi rst step in the assembly of the viral particle. A novel assay was developed to discover small molecule inhibitors of core dimerization. This assay is based on time-resolved fl uorescence resonance energy transfer (TR-FRET) between anti-tag antibodies labeled with either europium cryptate (Eu) or allophycocyanin (XL-665